Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Richman

Showing results (391-400 of 792) with videos related to

Pageof 80
Sort By:
Health Affairs (Project Hope)|August 1, 2022
Billing And Insurance-Related Administrative Costs: A Cross-National AnalysisBarak D Richman, Robert S Kaplan, Japees Kohli, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Interferon gene expression following HIV type 1 infection of monocyte-derived macrophagesChristopher H Woelk, Florence Ottones, Christine R Plotkin, et al.
The Journal of Infectious Diseases|December 23, 1999
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapyT Schacker, S Little, E Connick, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complexA W Wu, W C Mathews, L T Brysk, et al.
AIDS (London, England)|April 20, 1999
Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissueL Ruiz, J van Lunzen, A Arno, et al.
Annals of Internal Medicine|May 15, 1990
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials GroupM A Fischl, D D Richman, N Hansen, et al.
Journal of Virology|March 3, 2007
Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1C M Noviello, S L Kosakovsky Pond, M J Lewis, et al.
JAMA|November 3, 1989
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working GroupM A Fischl, D D Richman, D M Causey, et al.
Journal of Clinical Pathology|September 10, 2015
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trialSusan D Richman, Richard Adams, Phil Quirke, et al.
Frontiers in Immunology|May 1, 2018
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat TreatmentCory H White, Nadejda Beliakova-Bethell, Steven M Lada, et al.
Pageof 80

Showing results (391-400 of 792) with videos related to

Sort By:
Pageof 80
Health Affairs (Project Hope)|August 1, 2022
Billing And Insurance-Related Administrative Costs: A Cross-National AnalysisBarak D Richman, Robert S Kaplan, Japees Kohli, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Interferon gene expression following HIV type 1 infection of monocyte-derived macrophagesChristopher H Woelk, Florence Ottones, Christine R Plotkin, et al.
The Journal of Infectious Diseases|December 23, 1999
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapyT Schacker, S Little, E Connick, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complexA W Wu, W C Mathews, L T Brysk, et al.
AIDS (London, England)|April 20, 1999
Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissueL Ruiz, J van Lunzen, A Arno, et al.
Annals of Internal Medicine|May 15, 1990
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials GroupM A Fischl, D D Richman, N Hansen, et al.
Journal of Virology|March 3, 2007
Maintenance of Nef-mediated modulation of major histocompatibility complex class I and CD4 after sexual transmission of human immunodeficiency virus type 1C M Noviello, S L Kosakovsky Pond, M J Lewis, et al.
JAMA|November 3, 1989
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working GroupM A Fischl, D D Richman, D M Causey, et al.
Journal of Clinical Pathology|September 10, 2015
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trialSusan D Richman, Richard Adams, Phil Quirke, et al.
Frontiers in Immunology|May 1, 2018
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat TreatmentCory H White, Nadejda Beliakova-Bethell, Steven M Lada, et al.
Pageof 80